These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 29774408

  • 1. Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity.
    Anon B, Largeau B, Girault A, Chantome A, Caulet M, Perray C, Moussata D, Vandier C, Barin-Le Guellec C, Lecomte T.
    Cancer Chemother Pharmacol; 2018 Jul; 82(1):149-157. PubMed ID: 29774408
    [Abstract] [Full Text] [Related]

  • 2. Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicity.
    Argyriou AA, Antonacopoulou AG, Alberti P, Briani C, Bruna J, Velasco R, Anastopoulou GG, Park SB, Cavaletti G, Kalofonos HP.
    J Peripher Nerv Syst; 2019 Dec; 24(4):298-303. PubMed ID: 31486252
    [Abstract] [Full Text] [Related]

  • 3. SK3 Gene Polymorphism Is Associated with Taxane Neurotoxicity and Cell Calcium Homeostasis.
    Rua C, Guéguinou M, Soubai I, Viel E, Potier-Cartereau M, Chantome A, Barbe C, Bougnoux P, Barin-Le Guellec C, Vandier C.
    Clin Cancer Res; 2018 Nov 01; 24(21):5313-5320. PubMed ID: 30037821
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Genetic association study of a polymorphic CAG repeats array of calcium-activated potassium channel (KCNN3) gene and schizophrenia among the Chinese population from Taiwan.
    Tsai MT, Shaw CK, Hsiao KJ, Chen CH.
    Mol Psychiatry; 1999 May 01; 4(3):271-3. PubMed ID: 10395218
    [Abstract] [Full Text] [Related]

  • 6. Schizophrenia and polymorphic CAG repeats array of calcium-activated potassium channel (KCNN3) gene in Serbian population.
    Ivković M, Ranković V, Tarasjev A, Orolicki S, Damjanović A, Paunović VR, Romac S.
    Int J Neurosci; 2006 Feb 01; 116(2):157-64. PubMed ID: 16393881
    [Abstract] [Full Text] [Related]

  • 7. Association analysis of a highly polymorphic CAG Repeat in the human potassium channel gene KCNN3 and migraine susceptibility.
    Curtain R, Sundholm J, Lea R, Ovcaric M, MacMillan J, Griffiths L.
    BMC Med Genet; 2005 Sep 14; 6():32. PubMed ID: 16162291
    [Abstract] [Full Text] [Related]

  • 8. Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study.
    Argyriou AA, Cavaletti G, Antonacopoulou A, Genazzani AA, Briani C, Bruna J, Terrazzino S, Velasco R, Alberti P, Campagnolo M, Lonardi S, Cortinovis D, Cazzaniga M, Santos C, Psaromyalou A, Angelopoulou A, Kalofonos HP.
    Cancer; 2013 Oct 01; 119(19):3570-7. PubMed ID: 23821303
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. No evidence for involvement of KCNN3 (hSKCa3) potassium channel gene in familial and isolated cases of schizophrenia.
    Bonnet-Brilhault F, Laurent C, Campion D, Thibaut F, Lafargue C, Charbonnier F, Deleuze JF, Ménard JF, Jay M, Petit M, Frebourg T, Mallet J.
    Eur J Hum Genet; 1999 Oct 01; 7(2):247-50. PubMed ID: 10196711
    [Abstract] [Full Text] [Related]

  • 15. Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome.
    Bauer CK, Schneeberger PE, Kortüm F, Altmüller J, Santos-Simarro F, Baker L, Keller-Ramey J, White SM, Campeau PM, Gripp KW, Kutsche K.
    Am J Hum Genet; 2019 Jun 06; 104(6):1139-1157. PubMed ID: 31155282
    [Abstract] [Full Text] [Related]

  • 16. Effects of Goshajinkigan (TJ-107) for oxaliplatin-induced peripheral neurotoxicity using the functional assessment of cancer therapy/gynecologic oncology group 12-item neurotoxicity questionnaire in a Phase II, multicenter, randomized, double-blind, placebo-controlled trial.
    Aoyama T, Morita S, Kono T, Hata T, Mishima H, Sakamoto J.
    J Cancer Res Ther; 2021 Jun 06; 17(6):1473-1478. PubMed ID: 34916380
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
    Tsuruta A, Yamashita K, Tanioka H, Tsuji A, Inukai M, Yamakawa T, Yamatsuji T, Yoshimitsu M, Toyota K, Yamano T, Nagasaka T, Okajima M.
    Drug Des Devel Ther; 2016 Jun 06; 10():3827-3835. PubMed ID: 27920498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.